About: CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. The company develops leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. Its leronlimab completed phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.23 (+2.22%)
CYDY NYSE Cytodyn Inc
Cytodyn Inc share price
CYDY price activity
Last Price
$0.220
Change (24hr)
-0.01 USD (3.43%)
Volume
796.02K
Volume (4w avg)
-
Open
$0.23
Day Range
$0.22 - $0.24
Previous Close
$0.23
Last Trade
20 Nov, 8:57 pm GMT+0
Delayed
20 Nov, 8:57 pm GMT+0
CYDY price performance
Delayed
20 Nov, 8:57 pm GMT+0
CYDY details
CYDY Market Signals